Previous close | 26.51 |
Open | 26.81 |
Bid | 25.46 x 900 |
Ask | 42.48 x 1100 |
Day's range | 26.38 - 27.40 |
52-week range | 13.19 - 27.97 |
Volume | |
Avg. volume | 393,520 |
Market cap | 1.642B |
Beta (5Y monthly) | -0.01 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Treace Medical Concepts' estimated fair value is US$26.10 based on 2 Stage Free Cash Flow to Equity...
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of 0% and 6.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
With a price-to-sales (or "P/S") ratio of 11.2x Treace Medical Concepts, Inc. ( NASDAQ:TMCI ) may be sending very...
Treace Medical Concepts (TMCI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Shares of Treace Medical Concepts (NASDAQ: TMCI) were up 21% as of 3 p.m. EST Wednesday afternoon. The orthopedic medical device company's shares rose after it reported fourth-quarter earnings after the markets closed on Tuesday. Treace makes Lapiplasty surgery kits, which orthopedic surgeons use to perform minimally invasive surgery on bunions.
It's been a soft week for Treace Medical Concepts, Inc. ( NASDAQ:TMCI ) shares, which are down 10%. While that might be...
A look at the shareholders of Treace Medical Concepts, Inc. ( NASDAQ:TMCI ) can tell us which group is most powerful...
Treace Medical Concepts (TMCI) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Treace Medical Concepts (TMCI) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Treace Medical Concepts (TMCI) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Treace Medical Concepts ( NASDAQ:TMCI ) Third Quarter 2022 Results Key Financial Results Revenue: US$33.1m (up 53% from...
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of 21.43% and 9.83%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Over the last year, a good number of insiders have significantly increased their holdings in Treace Medical Concepts...
Treace Medical Concepts (TMCI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Treace Medical Concepts, Inc. ( NASDAQ:TMCI ) last week reported its latest quarterly results, which makes it a good...
Participating from the company today will be John Treace, chief executive officer, and Mark Hair, chief financial officer. Before we begin, we would like to remind you that it is our intent that all forward-looking statements made during this call will be protected under the Private Securities Litigation Reform Act of 1995. Any statements that relate to expectations or predictions of future events and market trends, as well as our estimated results or performance, are forward-looking statements.
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of -9.52% and 4.38%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Sensus Healthcare, Inc. (SRTS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
The big shareholder groups in Treace Medical Concepts, Inc. ( NASDAQ:TMCI ) have power over the company. Generally...
Treace Medical Concepts (TMCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.